...
首页> 外文期刊>Cell death & disease. >PARP12 (ARTD12) suppresses hepatocellular carcinoma metastasis through interacting with FHL2 and regulating its stability
【24h】

PARP12 (ARTD12) suppresses hepatocellular carcinoma metastasis through interacting with FHL2 and regulating its stability

机译:PARP12(ARTD12)通过与FHL2相互作用并调节其稳定性来抑制肝癌转移

获取原文
           

摘要

PARP12 is a mono-ADP-ribosyltransferase, but its function remains largely unknown. Here, we identified four-and-a-half LIM-only protein 2 (FHL2) as a functional partner of PARP12 through protein affinity purification. Although PARP12 did not mono-ADP-ribosylate FHL2 in vitro and in vivo, PARP12 deficiency decreased the protein level of FHL2 by promoting its ubiquitination and increased the expression level of transforming growth factor beta1 (TGF-β1), which is independent of PARP12 enzymatic activity. We also provided evidence that PARP12 deficiency increased the migration and invasion of hepatocellular carcinoma (HCC) cells and promoted HCC metastasis in vivo by regulating the epithelial–mesenchymal transition process. These results indicated that PARP12 is a tumor suppressor that plays an important role in HCC metastasis through the regulation of FHL2 stability and TGF-β1 expression.
机译:PARP12是一种单ADP-核糖基转移酶,但其功能仍然未知。在这里,我们通过蛋白亲和纯化将四个半LIM唯一蛋白2(FHL2)确定为PARP12的功能伙伴。尽管PARP12在体外和体内均未单-ADP-核糖基化FHL2,但PARP12缺乏通过促进泛素化而降低了FHL2的蛋白质水平,并增加了独立于PARP12酶促转化因子β1(TGF-β1)的表达水平。活动。我们还提供了证据,即PARP12缺乏通过调节上皮-间质转化过程而增加了肝细胞癌(HCC)细胞的迁移和侵袭,并在体内促进了HCC转移。这些结果表明,PARP12是通过抑制FHL2稳定性和TGF-β1表达在HCC转移中起重要作用的抑癌剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号